Part 3/7:
Following his diagnosis, Josh was faced with conventional treatment options that had limited success. His cancer had already spread, evident in tumors visible on scans, and previous rounds of chemotherapy had failed to halt its progression. Recognizing the need for something different, he connected with Dr. Timmerman—a leading oncologist noted for his work in novel cancer therapies.
It was Dr. Timmerman who introduced Josh to the revolutionary concept of immunotherapy, specifically CAR T-cell therapy. Unlike traditional treatments, CAR T-cell therapy involves re-engineering a patient’s own immune cells to better recognize and destroy cancer cells. This personalized approach offers a new hope where other treatments may have fallen short.